期刊文献+

C-反应蛋白与高血压合并糖尿病心肌纤维化的研究进展 被引量:1

下载PDF
导出
摘要 随着社会经济的发展,无论是发展中国家还是发达国家,高血压与糖尿病已成为引发心血管疾病发生发展的重要危险因素,而罹患高血压合并糖尿病的患者正逐年增加。据国内相关报道,高血压合并糖尿病的发生率高达20%~40%,高血压常与糖代谢紊乱并存,
作者 杜晓 闫旭龙
出处 《包头医学院学报》 CAS 2013年第3期122-124,共3页 Journal of Baotou Medical College
  • 相关文献

参考文献19

  • 1Ridker PM, Rifai N, Rose L, et al. Comparison of C - reactive protein and low density lipoprotein in cholesterol levels in the prediction of first cardiovascular events [ J ]. N Engl J Med, 2002,347 (20) : 1557 - 1565.
  • 2Leinonnen E, Hurt- Camejo E, Wiklund O, et al. Insulin resistance and adiposity correlate with acute -phase reaction and soluble cell adhesion molecules in type 2 diabetes [J]. Atherosclerosis ,2003,166 (2) :387 -394.
  • 3Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly [ J ]. Diabetes ,2001,50:2384 - 2389.
  • 4Pepys MB, Hirschfield GM. C - reactive protein: a critical update [J]. J Clin Invest ,2003,111 (12) :1805 - 1812.
  • 5Jabs WJ,Logering BA, Gerke P, et al. The kidney as a second site of human C - reactive protein formation in vivo [ J ]. Eur J Immunol, 2003,33(1) :152 - 161.
  • 6Marnell L, Mold C, Du Clos TW. C - reactive protein : ligands, receptors and role in inflammation [ J ]. Clin Immunol, 2005,117 ( 2 ) : 104 -111.
  • 7Du Clos TW,Mold C. C - reaetive protein: an activator of innate im- munity and a modulator of adaptive immunity [ J ]. Immunol Res, 2004,30(3) :261 -277.
  • 8Lu J, Marnell LL, Marion KD, et al. Structural recognition and functional activation of FcR by innate pentraxins [ J ]. Nature,2008,456 (7224) :989 - 992.
  • 9Mold C, Gresham HD, Du Clos TW. Serum amyloid P component and C -reactive protein mediate phagocytosis through routine Fc gamma Rs [ I ]. J Immunol,2001,166 (2) : 1200 - 1205.
  • 10Agrawal A, Shrive AK, Greenhough TJ, et al. Topology and structure of the Clq -binding site on C -reactive protein [ J]. J Immunol, 2001,166(6) :3998 -4004.

二级参考文献13

  • 1李呐,邓海,夏小杰.他汀类药物与高血压[J].实用医技杂志,2004,11(07B):1303-1305. 被引量:7
  • 2李建军.高血压可能是一种炎症相关性疾病[J].高血压杂志,2005,13(9):526-527. 被引量:46
  • 3吴进寿,洪华山.高血压与炎症关系的研究进展[J].中国临床药理学与治疗学,2006,11(2):136-140. 被引量:47
  • 4龚艺,徐劲松,苏海,王卫.他汀类药物对高胆固醇血症患者炎症因子和红细胞膜脂肪酸的影响[J].中国实用内科杂志,2007,27(3):193-195. 被引量:21
  • 5杨永超,周若锋.高血压病患者血清Hs-CRP的变化及辛伐他汀的干预作用[J].江西医药,2007,42(1):29-31. 被引量:5
  • 6[2]Makin AJ,Blann AD,Chung NA,et al.Assessment of endot-helial damage in atherosclerotic vascular diSease by quanti-fication of circulating endothelial cells relationship with von Willebrand factor and tissue factor[J].Eur Heart J,2004,25(5):3741~373.
  • 7[3]Albert MA,Danielson E,Rifai N,et al.Effect of statins therapy on creactive protein levels.the pravastatin infammatory/CRP evaluation(PRNCE):a randomized trial and cohort study[J].JAMA,2001,286(I):64~70.
  • 8[5]Hayaishi-Okano R,Yamasaki Y,Katakami N,ct el.Elevated C-reactive protein associates with early stage carotid ath erosclerosis in young subjects with type 1 diabets[J].Diabe-tes Care,2002,25(10).1432~1438.
  • 9[7]Kureishi Y,luo Z,Shiojilma I,et al.The HMG-CoA reduc-tase inhibitor sirastatin activatcs the protein kinase AKt and promotes angiogenesis in normocholestrmic animels[J].Nat Med,2000,6(10):1004~1010.
  • 10[10]Fichtlscherer S,Rosenberger G,Walter DH,et al.Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease[J].Circulation,2000,102(11):1000~1006.

共引文献23

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部